StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.05 (-5.21%)

Close on Nov 17, 2026Market cap $3.99MP/E –Yield –

Sonoma Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Sonoma Pharmaceuticals's total debt was $140.00K at Jun 30, 2026. For fiscal 2026 it was $222.00K, up 0.9% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $3.24M in fiscal 2012.

Annual total debt

PeriodPeriod endValueChange
FY2026Mar 31, 2026$222.00K+0.9%
FY2025Mar 31, 2025$220.00K-31.9%
FY2024Mar 31, 2024$323.00K-25.1%
FY2023Mar 31, 2023$431.00K–
FY2022Mar 31, 2022$0-100.0%
FY2021Mar 31, 2021$1.91M+296.3%
FY2020Mar 31, 2020$481.00K+44.0%
FY2019Mar 31, 2019$334.00K+27.5%
FY2018Mar 31, 2018$262.00K+56.0%
FY2017Mar 31, 2017$168.00K+47.4%
FY2016Mar 31, 2016$114.00K+31.0%
FY2015Mar 31, 2015$87.00K-40.8%
FY2014Mar 31, 2014$147.00K-92.4%
FY2013Mar 31, 2013$1.94M-40.3%
FY2012Mar 31, 2012$3.24M+27.3%
FY2011Mar 31, 2011$2.55M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$140.00K+0.7%
Q4 FY2026CQ1 2026Mar 31, 2026$222.00K+0.9%
Q3 FY2026CQ4 2025Dec 31, 2025$0–
Q2 FY2026CQ3 2025Sep 30, 2025$56.00K-31.7%
Q1 FY2026CQ2 2025Jun 30, 2025$139.00K-31.9%
Q4 FY2025CQ1 2025Mar 31, 2025$220.00K-31.9%
Q3 FY2025CQ4 2024Dec 31, 2024$0-100.0%
Q2 FY2025CQ3 2024Sep 30, 2024$82.00K+446.7%
Q1 FY2025CQ2 2024Jun 30, 2024$204.00K+1260.0%
Q4 FY2024CQ1 2024Mar 31, 2024$323.00K+2053.3%
Q4 FY2023CQ1 2023Mar 31, 2023$431.00K–
Q3 FY2023CQ4 2022Dec 31, 2022$15.00K–
Q2 FY2023CQ3 2022Sep 30, 2022$15.00K–
Q1 FY2023CQ2 2022Jun 30, 2022$15.00K-99.2%
Q4 FY2022CQ1 2022Mar 31, 2022$0-100.0%
Q2 FY2022CQ3 2021Sep 30, 2021$0-100.0%
Q1 FY2022CQ2 2021Jun 30, 2021$0-100.0%
Q4 FY2021CQ1 2021Mar 31, 2021$1.91M+296.3%
Q3 FY2021CQ4 2020Dec 31, 2020$1.31M–
Q2 FY2021CQ3 2020Sep 30, 2020$1.36M+1182.1%
Q1 FY2021CQ2 2020Jun 30, 2020$1.58M+646.4%
Q4 FY2020CQ1 2020Mar 31, 2020$481.00K+44.0%
Q3 FY2020CQ4 2019Dec 31, 2019$0-100.0%
Q2 FY2020CQ3 2019Sep 30, 2019$106.00K+7.1%
Q1 FY2020CQ2 2019Jun 30, 2019$211.00K-5.4%
Q4 FY2019CQ1 2019Mar 31, 2019$334.00K+27.5%
Q3 FY2019CQ4 2018Dec 31, 2018$22.00K-53.2%
Q2 FY2019CQ3 2018Sep 30, 2018$99.00K+12.5%
Q1 FY2019CQ2 2018Jun 30, 2018$223.00K+72.9%
Q4 FY2018CQ1 2018Mar 31, 2018$262.00K+56.0%
Q3 FY2018CQ4 2017Dec 31, 2017$47.00K-21.7%
Q2 FY2018CQ3 2017Sep 30, 2017$88.00K+12.8%
Q1 FY2018CQ2 2017Jun 30, 2017$129.00K–
Q4 FY2017CQ1 2017Mar 31, 2017$168.00K–
Q3 FY2017CQ4 2016Dec 31, 2016$60.00K–
Q2 FY2017CQ3 2016Sep 30, 2016$78.00K–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?